Strategic Partnerships Pint Pharma’s ongoing LATAM collaborations with global biopharma players for registration and promotion of therapies in Brazil, Argentina, Colombia, Chile, Peru, and Ecuador present ready-made routes for new partners seeking regional access and co-promotion opportunities.

Therapy Focus The company targets high-need areas such as cancer and rare diseases, signaling strong demand pockets where innovative therapies can differentiate Pint Pharma’s portfolio and drive premium launches across Latin America.

Regional Footprint Operating across multiple LATAM markets with a Europe-based headquarters and local teams suggests scalable entry points for new drugs, enabling expedited market access strategies and diversified risk across countries.

Portfolio Expansion Existing licenses and collaborations for hematology and oncology agents indicate Pint Pharma’s openness to additional licensed products, creating clear upsell opportunities with manufacturers seeking regional commercialization.

Commercial Capabilities With a substantial regional presence and experience in registering and promoting therapies, Pint Pharma can offer end-to-end services from regulatory clearance to market launch, making it attractive for partners seeking turnkey LATAM commercialization.